CRAT anticorps (N-Term)
Aperçu rapide pour CRAT anticorps (N-Term) (ABIN6261019)
Antigène
Voir toutes CRAT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- CRAT Antibody detects endogenous levels of total CRAT.
-
Homologie
- Bovine,Horse,Sheep,Rabbit,Dog,Chicken
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human CRAT, corresponding to a region within N-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Date de péremption
- 12 months
-
-
- CRAT (Carnitine O-Acetyltransferase (CRAT))
-
Autre désignation
- CRAT
-
Sujet
-
Description: Carnitine acetylase is specific for short chain fatty acids. Carnitine acetylase seems to affect the flux through the pyruvate dehydrogenase complex. It may be involved as well in the transport of acetyl-CoA into mitochondria.
Gene: CRAT
-
Poids moléculaire
- 55-68 kDa
-
ID gène
- 1384
-
UniProt
- P43155
-
Pathways
- Monocarboxylic Acid Catabolic Process
Antigène
-